Quoin Pharmaceuticals
QNRX
22 hedge funds and large institutions have $7.82M invested in Quoin Pharmaceuticals in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 3 closing their positions.
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
75% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 4
16% more funds holding
Funds holding: 19 → 22 (+3)
36% less capital invested
Capital invested by funds: $12.2M → $7.82M (-$4.34M)
69.99% less ownership
Funds ownership: 143.3% → 73.3% (-70%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$1.78M |
| 2 |
VCIM
Velan Capital Investment Management
Alpharetta,
Georgia
|
+$769K |
| 3 |
CC
Centiva Capital
New York
|
+$434K |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$432K |
| 5 |
SC
SummitTX Capital
Fort Worth,
Texas
|
+$322K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
-$840K |
| 2 |
RCAP
Resolute Capital Asset Partners
Denver,
Colorado
|
-$433K |
| 3 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
-$252K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$224K |
| 5 |
GI
GAMMA Investing
Foster City,
California
|
-$3.3K |
QNRX Hedge Fund Activity: Q1 2026 in Review
22 of the 8,197 institutional investors tracked by Wall St. Rank reported a position in Quoin Pharmaceuticals (QNRX) for Q1 2026, worth a combined $7.82M — down 36% from $12.2M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new QNRX positions and 3 closed out — a net gain of 3 holders — while 7 added to existing stakes and 4 trimmed.
The largest buyer was Dauntless Investment Group, opening a new position worth an estimated $1.78M. The largest seller was ADAR1 Capital Management, exiting entirely with an estimated $840K sold.
- 22 institutional investors held Quoin Pharmaceuticals (QNRX) as of Q1 2026, up from 19 in Q4 2025.
- Funds reported $7.82M of Quoin Pharmaceuticals stock for Q1 2026, down 36% quarter-over-quarter.
- 6 funds opened new Quoin Pharmaceuticals positions in Q1 2026 and 3 closed out, a net change of +3 holders.
- The largest Quoin Pharmaceuticals buyer in Q1 2026 was Dauntless Investment Group, an estimated $1.78M added.
- The largest Quoin Pharmaceuticals seller in Q1 2026 was ADAR1 Capital Management, an estimated $840K sold.
Based on aggregated 13F filings for Q1 2026.